Description:

E1105 Material Submission Form NCT00520975 First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17221122-2E12-611D-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17221122-2E12-611D-E044-0003BA3F9857

Versions (4)
  1. 8/26/12 8/26/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 7/3/15 7/3/15 -
Uploaded on:

July 3, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

E1105 Material Submission Form NCT00520975

English
Details

Complete the indicated sections of this form. All samples must be listed, thus multiple forms may be completed per patient. Submit the forms WITH the material(s) to the central laboratory indicated in the protocol.

1 forms  
Header
Reporting Period
Completed By Submitting Institutions
Shipped to
Informed consent signed?
Sample submission
3 more items in the detailed view.
Timing of material collection
Completed By Central Lab
Condition of Specimen (s)
Contacts
Comments
Back to the top of the page

Similar models

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial